Literature DB >> 30663848

Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.

Zhilian Hu1, Kari I Lavik1, Yang Liu1, Andy H Vo1, Catherine E Richter1, Jorge Di Paola2, Jordan A Shavit1.   

Abstract

Essentials Loss of fibrinogen in zebrafish has been previously shown to result in adult onset hemorrhage Hemostatic defects were discovered in early fga-/- embryos but well tolerated until adulthood Afibrinogenemia and thrombocytopenia results in synthetic lethality in zebrafish. Testing human FGA variants of uncertain significance in zebrafish identified causative mutations
SUMMARY: Background Mutations in the alpha chain of fibrinogen (FGA), such as deficiencies in other fibrinogen subunits, lead to rare inherited autosomal recessive hemostatic disorders. These range from asymptomatic to catastrophic life-threatening bleeds and the molecular basis of inherited fibrinogen deficiencies is only partially understood. Zinc finger nucleases have been used to produce mutations in zebrafish fga, resulting in overt adult-onset hemorrhage and reduced survival. Objectives To determine the age of onset of hemostatic defects in afibrinogenemic zebrafish and model human fibrinogen deficiencies. Methods TALEN genome editing (transcription activator-like effector nucleases) was used to generate a zebrafish fga mutant. Hemostatic defects were assessed through survival, gross anatomical and histological observation and laser-induced endothelial injury. Human FGA variants with unknown pathologies were engineered into the orthologous positions in zebrafish fga. Results Loss of Fga decreased survival and resulted in synthetic lethality when combined with thrombocytopenia. Zebrafish fga mutants exhibit a severe hemostatic defect by 3 days of life, but without visible hemorrhage. Induced thrombus formation through venous endothelial injury was completely absent in mutant embryos and larvae. This hemostatic defect was restored by microinjection of wild-type fga cDNA plasmid or purified human fibrinogen. This system was used to determine whether unknown human variants were pathological by engineering them into fga. Conclusions These studies confirm that loss of fibrinogen in zebrafish results in the absence of hemostasis from the embryonic period through adulthood. When combined with thrombocytopenia, zebrafish exhibit synthetic lethality, demonstrating that thrombocytes are necessary for survival in response to hemorrhage.
© 2019 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  fibrinogen; genome editing; hemostasis; thrombocytopenia; zebrafish

Year:  2019        PMID: 30663848      PMCID: PMC6443434          DOI: 10.1111/jth.14391

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  64 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Fibrinogen Montreal: a novel missense mutation (Aa D496N) associated with hypofibrinogenaemia.

Authors:  Campbell R Sheen; Stephen O Brennan; Nada Jabado; Peter M George
Journal:  Thromb Haemost       Date:  2006-08       Impact factor: 5.249

3.  Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V.

Authors:  J Cui; K S O'Shea; A Purkayastha; T L Saunders; D Ginsburg
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

4.  Fib420, the novel fibrinogen subclass: newborn levels are higher than adult.

Authors:  G Grieninger; X Lu; Y Cao; Y Fu; B J Kudryk; D K Galanakis; K M Hertzberg
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

5.  Analysis of blood coagulation in the zebrafish.

Authors:  P Jagadeeswaran; J P Sheehan
Journal:  Blood Cells Mol Dis       Date:  1999 Jun-Aug       Impact factor: 3.039

6.  Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.

Authors:  J Levin; J P Peng; G R Baker; J L Villeval; P Lecine; S A Burstein; R A Shivdasani
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

7.  Ubiquitous transgene expression and Cre-based recombination driven by the ubiquitin promoter in zebrafish.

Authors:  Christian Mosimann; Charles K Kaufman; Pulin Li; Emily K Pugach; Owen J Tamplin; Leonard I Zon
Journal:  Development       Date:  2011-01       Impact factor: 6.868

8.  Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.

Authors:  Zhilian Hu; Yang Liu; Michael C Huarng; Marzia Menegatti; Deepak Reyon; Megan S Rost; Zachary G Norris; Catherine E Richter; Alexandra N Stapleton; Neil C Chi; Flora Peyvandi; J Keith Joung; Jordan A Shavit
Journal:  Blood       Date:  2017-06-02       Impact factor: 22.113

9.  Targeted mutation of zebrafish fga models human congenital afibrinogenemia.

Authors:  Richard J Fish; Corinne Di Sanza; Marguerite Neerman-Arbez
Journal:  Blood       Date:  2014-02-19       Impact factor: 22.113

10.  Targeted gene disruption in somatic zebrafish cells using engineered TALENs.

Authors:  Jeffry D Sander; Lindsay Cade; Cyd Khayter; Deepak Reyon; Randall T Peterson; J Keith Joung; Jing-Ruey J Yeh
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

View more
  6 in total

1.  Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.

Authors:  Rui Vilar; Samuel W Lukowski; Marco Garieri; Corinne Di Sanza; Marguerite Neerman-Arbez; Richard J Fish
Journal:  Thromb Haemost       Date:  2020-12-10       Impact factor: 5.249

2.  Thrombocyte Inhibition Restores Protective Immunity to Mycobacterial Infection in Zebrafish.

Authors:  Elinor Hortle; Khelsey E Johnson; Matt D Johansen; Tuong Nguyen; Jordan A Shavit; Warwick J Britton; David M Tobin; Stefan H Oehlers
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

3.  A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis.

Authors:  Cristina Freire; Richard J Fish; Rui Vilar; Corinne Di Sanza; Steven J Grzegorski; Catherine E Richter; Jordan A Shavit; Marguerite Neerman-Arbez
Journal:  Blood Adv       Date:  2020-11-10

4.  Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders.

Authors:  Richard J Fish; Cristina Freire; Corinne Di Sanza; Marguerite Neerman-Arbez
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

Review 5.  Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish.

Authors:  Azhwar Raghunath; Allison C Ferguson; Jordan A Shavit
Journal:  Res Pract Thromb Haemost       Date:  2022-08-05

Review 6.  Fibrin(ogen) in human disease: both friend and foe.

Authors:  Rui Vilar; Richard J Fish; Alessandro Casini; Marguerite Neerman-Arbez
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.